Linked from

The 31 pages that link to Serotonin syndrome, each with the reason it gives.

• Drug interactionRelated: It illustrates how overlapping drug effects can produce acute toxicity.

• Selective serotonin reuptake inhibitorRelated: Combining SSRIs with other serotonergic agents can raise this serious safety risk.

• SerotoninRelated: This condition illustrates the risks of excessive serotonin signaling.

• Serotonin transporterRelated: Strongly increasing extracellular serotonin through transporter inhibition can contribute to this toxicity.

• Malignant hyperthermiaCompared with: It can cause fever and muscle abnormalities, but its characteristic neuromuscular findings differ.

• Neuroleptic malignant syndromeCompared with: It can resemble this syndrome, but clonus and hyperreflexia more strongly suggest serotonin toxicity.

• HyperthermiaBroader topic: Hyperthermia can occur when serotonergic toxicity drives muscle activity and autonomic instability.

• Monoamine oxidase inhibitorRelated: Combining MAO inhibitors with serotonergic drugs can precipitate this toxicity.

• OndansetronCompared with: Warnings about serotonergic combinations distinguish rare concerns from ondansetron's usual receptor-blocking action.

• LinezolidRelated: Linezolid inhibits monoamine oxidase and can interact with serotonergic medicines.

• Serotonin-norepinephrine reuptake inhibitorRelated: Combining an SNRI with other serotonergic drugs can raise this risk.

• Tricyclic antidepressantCompared with: This is a distinct medication toxicity; tricyclics are less strongly serotonergic than many SSRIs but can contribute, especially in combinations.

• DuloxetineRelated: Combining duloxetine with other serotonergic drugs can raise this risk.

• FluoxetineRelated: Fluoxetine can contribute to this syndrome, especially with other serotonergic drugs.

• SertralineRelated: Combining sertraline with other serotonin-raising substances can increase this risk.

• VenlafaxineRelated: Combining venlafaxine with other serotonergic drugs can increase this risk.

• BuspironeRelated: Risk can rise when buspirone is combined with other serotonergic medicines.

• Extrapyramidal symptomsCompared with: Its tremor and abnormal movements can be confused with medication-related extrapyramidal symptoms.

• Anticholinergic syndromeCompared with: Neuromuscular excitation and sweating distinguish it from the dry skin and reduced reflexes of anticholinergic toxicity.

• MDMARelated: Combining MDMA with other serotonergic substances can raise concern for dangerous serotonin toxicity.

• DextromethorphanRelated: Dextromethorphan can contribute to serotonin toxicity, especially with other serotonergic drugs.

• Delirium tremensCompared with: Its agitation and autonomic signs can resemble severe withdrawal, but medication exposure and examination distinguish it.

• ClomipramineRelated: Combining clomipramine with other serotonin-enhancing drugs can precipitate this toxicity.

• ParoxetineRelated: Combining paroxetine with other serotonergic drugs can raise this risk.

• TramadolRelated: Tramadol can contribute to this syndrome, especially when combined with other serotonergic drugs.

• EscitalopramRelated: Combining escitalopram with other serotonergic drugs can increase this risk.

• SelegilineRelated: Combining selegiline with certain serotonergic drugs can raise the risk of this reaction.

• TrazodoneRelated: Trazodone can contribute to this reaction, particularly when combined with other serotonin-raising medicines.

• PethidineRelated: Pethidine has serotonergic activity and can contribute to this syndrome when combined with serotonergic drugs.

• SumatriptanRelated: Combining sumatriptan with other serotonergic medicines can rarely contribute to this syndrome.

• FluvoxamineRelated: Combining fluvoxamine with other serotonin-enhancing substances can raise this risk.